Diabetes is a Significant and Independent Predictor for Tacrolimus Immediate Release (IR) and LCP-Tacrolimus (LCP) Conversion Ratios.

被引:0
|
作者
Coffman, K. S. [1 ]
Patel, N. [1 ]
Bartlett, F. [1 ]
Newman, J. [1 ]
Patel, S. [1 ]
Sprague, T. [1 ]
Rao, N. [1 ]
Andrade, E. [1 ]
Casey, M. [1 ]
Rohan, V. [1 ]
Dubay, D. [1 ]
Taber, D. [1 ]
机构
[1] Med Univ South Carolina, Charleston, SC 29425 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A177
引用
收藏
页码:679 / 679
页数:1
相关论文
共 29 条
  • [1] Diabetes is a significant and independent predictor for tacrolimus immediate release and LCP-tacrolimus conversion ratios
    Coffman, Kelsey
    Patel, Neha
    Bartlett, Felicia
    Newman, Jessica
    Patel, Shikha
    Sprague, Taylor
    Rao, Nikhil
    Andrade, Erika
    Casey, Michael J.
    Rohan, Vinayak
    DuBay, Derek
    Taber, David
    CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [2] Evaluation of Conversion from Immediate Release (IR) Tacrolimus to LCP-Tacrolimus (Envarsus XR®, LCP) in Heart Transplant Recipients.
    Foster, E.
    Iaria, A.
    Negrelli, J.
    Fine, M.
    Yu, M.
    Liebo, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 843 - 843
  • [3] Conversion of Tacrolimus Immediate Release to LCP-Tacrolimus in Non-Kidney Transplant Recipients
    Lucarelli, S. E.
    Le, T.
    Lichvar, A.
    Kerr, J.
    Kozuch, J.
    Tsunoda, S.
    Feist, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S581 - S582
  • [4] PHARMACOKINETIC ASSESSMENT OF TACROLIMUS EXPOSURE BEFORE AND AFTER A SWITCH FROM IMMEDIATE-RELEASE (IR) TO LCP-TACROLIMUS: THE ENVARSWITCH STUDY
    Monchaud, Caroline
    Woillard, Jean-Baptiste
    Tafzi, Naima
    Micallef, Ludovic
    Debette-Gratien, Marilyne
    Rerolle, Jean-Philippe
    Dharancy, Sebastien
    Conti, Filomena
    Gabriel, Choukroun
    Thierry, Antoine
    Buchler, Matthias
    Salame, Ephrem
    Garrouste, Cyril
    Duvoux, Christophe
    Colosio, Charlotte
    Merville, Pierre
    Anglicheau, Dany
    Etienne, Isabelle
    Saliba, Faouzi
    Mariat, Christophe
    Marquet, Pierre
    TRANSPLANT INTERNATIONAL, 2021, 34 : 346 - 346
  • [5] Conversion of Tacrolimus Immediate Release to LCP Tacrolimus in Obese Kidney Transplant Recipients.
    Newman, J.
    Patel, N.
    Patel, S.
    Sprague, T.
    Andrade, E.
    Rao, N.
    Bartlett, F.
    Dubay, D.
    Rohan, V.
    Casey, M.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 564 - 564
  • [6] Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-Tacrolimus
    Taber, David J.
    Bartlett, Felicia
    Patel, Neha
    Sprague, Taylor
    Patel, Shikha
    Newman, Jessica
    Andrade, Erika
    Rao, Nikhil
    Salas, Maria Aurora Posadas
    Casey, Michael
    Dubay, Derek
    Rohan, Vinayak
    CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [7] Early Tacrolimus Trough Attainment in De Novo Kidney Transplant Recipients Treated with LCP-Tacrolimus (LCPT) vs. Immediate-Release Tacrolimus (IR-Tac).
    Budde, K.
    Bunnapradist, S.
    Patel, S. J.
    Stevens, D. R.
    Meier-Kriesche, U.
    Suwelack, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 689 - 689
  • [8] Efficacy and Safety of LCP-Tacrolimus (Envarsus XR®) Conversion Therapy in Heart Transplantation
    Kim, M.
    Givertz, M. M.
    Stewart, G. C.
    Page, D. S.
    Woodcome, E. L.
    Mehra, M. R.
    Mehra, M. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S502 - S502
  • [9] Dosing and Exposure over 2 Years with LCP-Tacrolimus (LCPT) vs. Immediate-Release Tacrolimus (IR-Tac) in De Novo Kidney Transplantation
    Budde, K.
    Bunnapradist, S.
    Patel, S.
    Stevens, D.
    Meier-Kriesche, U.
    Suwelack, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 684 - 685
  • [10] LCP-Tacrolimus Requires a Similar Empiric Dose Adjustment to Immediate-Release Tacrolimus When Given Concomitantly With Letermovir for Cytomegalovirus Primary Prophylaxis
    Descourouez, Jillian L.
    Mandelbrot, Didier A.
    Odorico, Jon
    Jorgenson, Margaret R.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (08) : 870 - 871